Macrolides are a variety of antibiotics named broad-spectrum antibiotics whose purpose is to look after a variety of transmissions. Macrolides are arising from Streptomyces species. They include a typical macrolytic lactone ring to which if not more sugars are attached. These are not the same as the other with their chemical substitutions on structures of varied carbon atoms and also the amino and neutral sugars.
Macrolides are one of a typical oldest classes of antibiotics. Macrolide antibiotics have already been regarded on the list of best-tolerated antibiotics for almost fifty years. The very first member of the course, Erythromycin was discovered in 1952. Newer macrolides, azithromycin, clarithromycin and dithromycin are semi-synthetic macrolides similar in structure to erythromycin. These agents have been developed to overcome the problems associated with erythromycin. The newer macrolide antibiotics offer the benefit for fewer adverse gastrointestinal effects than erythromycin and dosing regimens of only once or two times each day. The newer macrolides can also have a broader spectrum of antibacterial activity than erythromycin. The latest series of macrolides, the ketolides, whose clinical utilization is within this early stage, are characterized by improved activity against some of the resistant strains.
Macrolides advantages and disadvantages
Macrolides disadvantages:
severe allergic skin reactions
cardiac arrhythmias
many drug interactions including prolonging INR
macrolide resistance is reported for 20%30% of Streptococcus pneumoniae
The newer Macrolides advantages:
broad antibacterial spectrum
simple to operate, convenient dosing regimens - daily or twice daily dosing regimen
side-effect profiles (low incidence of gastrointestinal negative effects). Essential aspects of the macrolide class is the excellent safety profile allowing prescription for usage broadly across all age groups
macrolide antibiotics, being a group, quite some time safe in pregnancy
excellent tissue and intracellular penetration
enhanced acid stabilities
Mechanism of impact
The mechanism of action of the macrolides is inhibition of bacterial protein synthesis by binding reversibly into the subunit 50S of many bacterial ribosome, thereby inhibiting translocation of peptidyl-tRNA. This action is mainly bacteriostatic (inhibition the build up and reproduction of bacteria), but will also be bactericidal in high concentrations. Macrolides tend to accumulate within leukocytes, and are also therefore actually transported on the site of infection.
Macrolides bind to the large ribosomal subunit around about the peptidyl transferase center and cause cell growth arrest due to inhibition of protein synthesis.
Macrolides spectrum of antibacterial undertaking
Macrolides have activity against many gram-positive bacteria (excluding enterococci and methicillin-resistant Staphylococcus aureus), and have absolutely variable activity against respiratory gram-negative pathogens, Mycobacterium avium infections, gonorrhea. Macrolide antibiotics are noted for their intracellular accumulation and activity against intracellular pathogens for example Mycoplasma pneumoniae, Chlamydia pneumoniae and Legionella spp. In addition to antimicrobial activities, macrolides can modify host cell functions.
Clarithromycin and azithromycin have similar spectrum to erythromycin but increased activity against Hemophilus, Mycobacterium avium intracellulare, and toxoplasma. Azithromycin has increased gram-negative activity, while clarithromycin has exploded gram-positive activity.
Spectrum of activity:
Gram-positive aerobes (Methicillin-susceptible Staphylococcus aureus, Streptococcus pneumoniae (only PSSP), Group and viridans streptococci, Bacillus sp., Corynebacterium sp.). Erythromycin and clarithromycin display the most effective activity (clarithromycin>erythromycin>azithromycin).
Gram-negative aerobes (H. influenzae, M. catarrhalis, Neisseria sp.). Newer macrolides (clarithromycin and azithromycin) have enhanced activity (azithromycin>clarithromycin>erythromycin).
Anaerobes. Activity against upper airway anaerobes.
Atypical bacteria. All macrolides have excellent activity against atypical bacteria including: Legionella pneumophila - DOC, Chlamydia sp., Mycoplasma sp., Ureaplasma urealyticum.
Other bacteria. Mycobacterium avium complex (MAC ? only An and C), Treponema pallidum, Campylobacter, Borrelia, Bordetella, Brucella, Pasteurella.
Conditions treated with Macrolides
Macrolide antibiotics have antibacterial activity against gram-positive bacteria, some gram-negative bacteria and intracellular pathogens. The spectrum of antibacterial activity coordinated with excellent intracellular and tissue penetration has led to the extensive consumption of this class of drugs in respiratory disease. Macrolide antibiotics even have demonstrated anti-inflammatory properties in a number of in vitro whereas in the vivo model systems.
Macrolides are used to diminish:
Respiratory tract infections (sinusitis, pharyngitis, lower respiratory tract infections)
Skin and soft tissue infections
Sexually transmitted diseases
Cervicitis, urethritis
Mycobacterial infections
H.pylori infections (clarithromycin, as part of triple therapy)
Macrolides extremely valuable alternatives to penicillins and cephalosporins in allergic patients.
This groupping antibiotics has long been often in kids for their antibacterial effects against diseases similar to diphtheria, pertussis, Mycoplasma pneumonia, Chlamydia pneumonia and Legionella.
Unwanted effects
The macrolides are well-tolerated agents. The commonest unwanted side effects are gastro-intestinal disturbances (nausea, vomiting, diarrhea, dyspepsia, abdominal pain and cramps). Unwanted effects are more common and severe with erythromycin therapy. Azithromycin and clarithromycin have fewer gastrointestinal negative effects than erythromycin.
Hypersensitivity, headache, taste disturbance, eosinophilia, reversible going deaf, and hepatotoxicity are an infrequent occurrence for all the macrolides. Macrolides should really be avoided in severe liver disease due to increased risk of hepatotoxicity and altered handling. Macrolide are contraindicated assuming there is usually a tradition of hypersensitivity.
Erythromycin is taken into account safe in pregnancy and breast feeding. Clarithromycin is safe in breast feeding (pregnancy category C). The research for safety of azithromycin is lacking, and utilize is therefore inadvisable unless benefit is considered to outweigh potential harm.
Drug activities
Macrolides are divided into 3 groups for likely occurrence of drug-drug interactions:
group 1 (e.g. erythromycin) are frequently involved
group 2 (e.g. clarithromycin) are less commonly involved
group 3 (e.g. azithromycin, dirithromycin) drug interactions have not been pointed out
Author Resource:-
Both erythromycin and clarithromycin inhibit the side effects of Celexa activity of the hepatic cytochrome P450 enzyme system. Consequently, these agents keep in check the metabolism and raise the serum concentration of other drugs eliminated from the P450 pathway. Azithromycin, on account of differences in its chemical structure, doesn't cause these interactions. These fundamental medications in some cases Pradaxa side effects be affected by erythromycin or clarithromycin:
![[Valid RSS feed]](http://article2008.com/images/feed-icon.png "XML Feed For RSS"){kind=icon}
![[Valid RSS feed]](http://article2008.com/images/icon_Rss.png "XML Feed For RSS"){kind=icon}
Category Rss Feed
Print This Article
Add To Favorites